APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 325 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $7,670,235 | -43.8% | 199,954 | -13.9% | 0.01% | -45.8% |
Q1 2024 | $13,651,244 | -77.0% | 232,243 | -64.3% | 0.02% | -81.7% |
Q2 2023 | $59,321,496 | +45.6% | 651,169 | +5.4% | 0.13% | +28.4% |
Q1 2023 | $40,756,486 | +207.5% | 617,897 | +141.0% | 0.10% | +183.3% |
Q4 2022 | $13,255,393 | +310.6% | 256,341 | +442.3% | 0.04% | +260.0% |
Q3 2022 | $3,228,000 | -46.9% | 47,265 | -63.2% | 0.01% | -52.4% |
Q4 2021 | $6,076,000 | +0.6% | 128,514 | -29.8% | 0.02% | -16.0% |
Q3 2021 | $6,037,000 | +465.8% | 183,147 | +205.2% | 0.02% | +400.0% |
Q3 2018 | $1,067,000 | -25.9% | 60,000 | -8.3% | 0.01% | -28.6% |
Q2 2018 | $1,439,000 | – | 65,428 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AJU IB Investment Co., Ltd. | 624,962 | $20,599,000 | 13.29% |
Octagon Capital Advisors LP | 1,595,911 | $52,601,000 | 12.95% |
Logos Global Management LP | 1,450,000 | $47,792,000 | 3.45% |
Avoro Capital Advisors LLC | 5,000,000 | $164,800,000 | 2.59% |
Ghost Tree Capital, LLC | 200,000 | $6,592,000 | 1.93% |
Integral Health Asset Management, LLC | 190,000 | $6,262,000 | 1.80% |
GREAT POINT PARTNERS LLC | 200,000 | $6,592,000 | 1.54% |
Aufman Associates Inc | 53,642 | $1,768,000 | 1.45% |
Ghost Tree Capital, LLC | 150,000 | $4,944,000 | 1.45% |
Altium Capital Management LP | 166,700 | $5,494,000 | 1.44% |